These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 9172009

  • 1. Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.
    Brema F, Pastorino G, Martini MC, Gottlieb A, Luzzani M, Libretti A, Saccà L, Cigolari S.
    Int J Clin Pharmacol Res; 1996; 16(4-5):109-16. PubMed ID: 9172009
    [Abstract] [Full Text] [Related]

  • 2. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 3. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 4. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R, Kayser H, Sittl R.
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [Abstract] [Full Text] [Related]

  • 5. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW.
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].
    Bono AV, Cuffari S.
    Drugs; 1997 Nov; 53 Suppl 2():40-9. PubMed ID: 9190324
    [Abstract] [Full Text] [Related]

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Nov; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M, Berggren AC.
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [Abstract] [Full Text] [Related]

  • 10. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
    Oifa S, Sydoruk T, White I, Ekstein MP, Marouani N, Chazan S, Skornick Y, Weinbroum AA.
    Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [Abstract] [Full Text] [Related]

  • 12. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M, Pekdemir M, Selekler HM.
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis.
    Roth SH.
    J Rheumatol; 1998 Jul; 25(7):1358-63. PubMed ID: 9676769
    [Abstract] [Full Text] [Related]

  • 14. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 15. [The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study].
    Schutter U, Ritzdorf I, Heckes B.
    MMW Fortschr Med; 2010 Jul 01; 152 Suppl 2():62-9. PubMed ID: 21591321
    [Abstract] [Full Text] [Related]

  • 16. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N, Sittl R, Likar R.
    Curr Med Res Opin; 2005 Aug 01; 21(8):1147-56. PubMed ID: 16083522
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
    Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K.
    J Pain Symptom Manage; 2004 Jul 01; 28(1):59-71. PubMed ID: 15223085
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
    Beaulieu AD, Peloso P, Bensen W, Clark AJ, Watson CP, Gardner-Nix J, Thomson G, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC.
    Clin Ther; 2007 Jan 01; 29(1):49-60. PubMed ID: 17379046
    [Abstract] [Full Text] [Related]

  • 19. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
    Vorsanger G, Xiang J, Jordan D, Farrell J.
    Clin Ther; 2007 Jan 01; 29 Suppl():2520-35. PubMed ID: 18164919
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
    Likar R, Wittels M, Molnar M, Kager I, Ziervogel G, Sittl R.
    Clin Ther; 2006 Dec 01; 28(12):2022-39. PubMed ID: 17296459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.